SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001047469-17-003556
Filing Date
2017-05-23
Accepted
2017-05-22 20:08:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 14D9 a2232214zsc14d9.htm SC 14D9 32532
  Complete submission text file 0001047469-17-003556.txt   34008
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filed by) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2834 Pharmaceutical Preparations

Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Subject) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-89113 | Film No.: 17862452
SIC: 2834 Pharmaceutical Preparations